Suppr超能文献

儿童特发性扩张型心肌病;自然病史和预后预测因素。

Idiopathic dilated cardiomyopathy in children; Natural history and predictors of prognosis.

机构信息

Pediatric Department- Cairo University, Cairo, Egypt.

出版信息

Libyan J Med. 2007 Sep 1;2(3):129-34. doi: 10.4176/070501.

Abstract

Dilated cardiomyopathy is the most common type of heart muscle disease in children with idiopathic etiology in the majority of cases. Idiopathic dilated cardiomyopathy (IDCM) is a severe illness which carries a high mortality rate in the pediatric population. In order to characterize IDCM evolution and identify prognostic predictors in our pediatric cardiology center in the western province of Saudi Arabia, 55 patients with IDCM were evaluated clinically and by echocardiography. They were followed for a minimum of one year and a maximum of four and a half years. Patients less than two years of age represented 69% of the cohort. Gender distribution revealed 65.5% female and 35.5% male. Outcomes were divided into four groups: 25 patients (45.5%) improved (Group I), 17 patients (31%) had a stationary course (Group II), 13 patients (23.6%) deteriorated (Group III), and eventually 11 patients (from Group III) died. Survival rate was 80% with a mean follow-up period of 36.2 ± 22.1 months. The older the age at presentation, the worse the prognosis, with P value= 0.029. In this study, we found a significant correlation of prognosis with end diastolic volume (EDV) (P=0.05) as well as stroke volume (SV) (P=0.04) on presentation. However, fractional shortening of ejection fraction on presentation could not be correlated statistically to the prognosis. Also results suggested that higher z-score of intraventricular septum & Left ventricular posterior wall dimensions in diastole significantly correlated to favorable outcomes and higher z-score of Left ventricular end diastolic dimension (LVEDD) was significantly related to unfavorable outcome. We concluded that further multi-center studies are necessary to verify predictors of outcome in IDCM patients. Identification of markers affecting early myocardial function is essential to achieving improvements in treatments and consequently outcomes in this pediatric population.

摘要

扩张型心肌病是儿童中最常见的以特发性病因为主的心肌疾病类型。特发性扩张型心肌病(IDCM)是一种严重疾病,在儿科人群中死亡率较高。为了描述我们在沙特阿拉伯西部省份的儿科心脏病学中心的 IDCM 演变,并确定预后预测因素,我们评估了 55 例 IDCM 患者的临床和超声心动图表现。他们的随访时间至少为 1 年,最长为 4 年半。年龄小于 2 岁的患者占队列的 69%。性别分布显示,女性占 65.5%,男性占 35.5%。结果分为四组:25 例(45.5%)患者改善(I 组),17 例(31%)患者病情稳定(II 组),13 例(23.6%)患者病情恶化(III 组),最终 11 例(来自 III 组)患者死亡。生存率为 80%,平均随访时间为 36.2±22.1 个月。发病时年龄越大,预后越差,P 值=0.029。在这项研究中,我们发现预后与舒张末期容积(EDV)(P=0.05)和收缩末期容积(SV)(P=0.04)有显著相关性。然而,射血分数的舒张末期分数在统计学上不能与预后相关。结果还表明,舒张期室内间隔和左心室后壁尺寸的 z 评分越高,结局越好,左心室舒张末期内径(LVEDD)的 z 评分越高,结局越差。我们得出结论,需要进一步的多中心研究来验证 IDCM 患者的预后预测因素。识别影响早期心肌功能的标志物对于改善该儿科人群的治疗和预后至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1d/3078205/0fb074c95341/LJM-2-129-g001.jpg

相似文献

6
Association of telomere length with diabetes mellitus and idiopathic dilated cardiomyopathy in a South Indian population: A pilot study.
Mutat Res Genet Toxicol Environ Mutagen. 2022 Feb-Mar;874-875:503439. doi: 10.1016/j.mrgentox.2021.503439. Epub 2021 Dec 31.
8
9
Pediatric idiopathic dilated cardiomyopathy: A single center experience.
J Nat Sci Biol Med. 2013 Jan;4(1):145-8. doi: 10.4103/0976-9668.107279.

引用本文的文献

1
Clinical and echocardiographic patterns and outcomes of Sudanese children with cardiomyopathy.
Sudan J Paediatr. 2021;21(2):131-136. doi: 10.24911/SJP.106-1600099020.
2
Paediatric dilated cardiomyopathy in Khartoum state, Sudan: a prospective study.
BMJ Paediatr Open. 2021 Apr 27;5(1):e000970. doi: 10.1136/bmjpo-2020-000970. eCollection 2021.
3
Prognostic impact of right bundle branch block in hospitalized patients with idiopathic dilated cardiomyopathy: a single-center cohort study.
J Int Med Res. 2020 Jan;48(1):300060518801478. doi: 10.1177/0300060518801478. Epub 2018 Oct 14.
4
Clinical and echocardiographic outcome in patients receiving carvedilol for treatment of dilated cardiomyopathy.
Indian J Pediatr. 2013 Jul;80(7):549-54. doi: 10.1007/s12098-012-0954-y. Epub 2013 Feb 15.

本文引用的文献

1
Dilated cardiomyopathy in childhood.
Images Paediatr Cardiol. 2000 Jan;2(1):3-10.
2
Incidence, causes, and outcomes of dilated cardiomyopathy in children.
JAMA. 2006 Oct 18;296(15):1867-76. doi: 10.1001/jama.296.15.1867.
3
Dilated cardiomyopathy in childhood: prognostic features and outcome.
Acta Cardiol. 2006 Apr;61(2):169-74. doi: 10.2143/AC.61.2.2014330.
5
Cardiac transplantation in pediatric patients: fifteen-year experience of a single center.
Ann Thorac Surg. 2005 Jan;79(1):53-60; discussion 61. doi: 10.1016/j.athoracsur.2003.12.075.
6
Recombinant human growth hormone treatment for dilated cardiomyopathy in children.
Pediatrics. 2004 Oct;114(4):e452-8. doi: 10.1542/peds.2004-0072.
7
Improved early outcome for end-stage dilated cardiomyopathy in children.
J Thorac Cardiovasc Surg. 2003 Dec;126(6):1781-7. doi: 10.1016/j.jtcvs.2003.07.029.
8
Dilated cardiomyopathy in Indian children.
Indian Heart J. 2003 Mar-Apr;55(2):147-51.
9
The epidemiology of childhood cardiomyopathy in Australia.
N Engl J Med. 2003 Apr 24;348(17):1639-46. doi: 10.1056/NEJMoa021737.
10
Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings.
Eur Heart J. 2003 Feb;24(3):280-8. doi: 10.1016/s0195-668x(02)00387-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验